Section 1 - National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 16 of 2004) - National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 16 of 2004)

COMMONWEALTH OF AUSTRALIA

National Health Act 1953

PHARMACEUTICAL BENEFITS

DECLARATION UNDER SUBSECTION 85(2AA)

No. PB 16 of 2004

I, JOAN CORBETT, Assistant Secretary, Pharmaceutical Benefits Branch, Department of Health and Ageing and Delegate of the Minister for Health and Ageing, having in accordance with subsection 85(2AB) of the National Health Act 1953 obtained the advice of the Pharmaceutical Benefits Advisory Committee, pursuant to subsection 85(2AA) of the National Health Act 1953 hereby make the following Declaration:

This Declaration commences on 1 December 2004.
The drugs and medicinal preparations specified in the Schedule to this Declaration shall cease to be drugs and medicinal preparations to which Part VII of the National Health Act 1953 applies.

THE SCHEDULE

Ammonium Chloride

Bendrofluazide

Omeprazole Magnesium and Clarithromycin and Amoxycillin Trihydrate

Rofecoxib

Sodium Nitroprusside

Timolol Maleate with Pilocarpine Hydrochloride

Dated this seventeenth day of November 2004.

JOAN CORBETT

Assistant Secretary

Pharmaceutical Benefits Branch

Department of Health and Ageing

Delegate of the Minister for Health and Ageing

1National Health Act 1953 - Declaration under subsection 85(2AA) (No. PB 16 of 2004)

Get a plain-English read of 1